Correction to ‘International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study’
Journal of the European Academy of Dermatology and Venereology · 2025-08 · 39 (8) · 1511-1511
DOI: 10.1111/jdv.20720 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 06.05.2025. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Caron AGM, van Huizen AM, Musters AAH, Gerbens LAA, Middelkamp Hup MA, Flohr C, et al. International Consensus on Methotrexate Dosing for Patients With Atopic Dermatitis: An eDelphi Study. Journal of the European Academy of Dermatology and Venereology. 2025; 39: 331–339. https://doi.org/10.1111/jdv.20271. In the Acknowledgement section, the middle name was omitted from the author name Michael Boffa. The correct name is Michael J Boffa. We apologize for this error.
Zitieren
APA
(2025). Correction to ‘International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study’. Journal of the European Academy of Dermatology and Venereology, 39(8), 1511-1511. https://doi.org/10.1111/jdv.20720
Vancouver
Correction to ‘International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study’. Journal of the European Academy of Dermatology and Venereology. 2025;39(8):1511-1511. doi:10.1111/jdv.20720
BibTeX
@article{euvimed2025,
title = {Correction to ‘International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study’},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {8},
pages = {1511--1511},
doi = {10.1111/jdv.20720}
}
EUVIMED